Correlation Between Pfizer and BankFirst Capital

Can any of the company-specific risk be diversified away by investing in both Pfizer and BankFirst Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and BankFirst Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and BankFirst Capital, you can compare the effects of market volatilities on Pfizer and BankFirst Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of BankFirst Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and BankFirst Capital.

Diversification Opportunities for Pfizer and BankFirst Capital

-0.75

Correlation Coefficient

Pfizer  BankFirst Capital

Pay attention - limited upside

The 3 months correlation between Pfizer and BankFirst is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and BankFirst Capital in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BankFirst Capital and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with BankFirst Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BankFirst Capital has no effect on the direction of Pfizer i.e., Pfizer and BankFirst Capital go up and down completely randomly.

Pair Corralation between Pfizer and BankFirst Capital

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the BankFirst Capital. In addition to that, Pfizer is 1.04 times more volatile than BankFirst Capital. It trades about -0.1 of its total potential returns per unit of risk. BankFirst Capital is currently generating about 0.13 per unit of volatility. If you would invest  3,749  in BankFirst Capital on September 18, 2024 and sell it today you would earn a total of  451.00  from holding BankFirst Capital or generate 12.03% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	98.44%
Values	Daily Returns

Pfizer Inc  vs.  BankFirst Capital

Pfizer Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

BankFirst Capital

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in BankFirst Capital are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak fundamental indicators, BankFirst Capital may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Pfizer and BankFirst Capital

The main advantage of trading using opposite Pfizer and BankFirst Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, BankFirst Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BankFirst Capital will offset losses from the drop in BankFirst Capital's long position.

The idea behind Pfizer Inc and BankFirst Capital pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.